Silver Rock Financial LP Bausch Health Companies Inc. Transaction History

Silver Rock Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$27.43 - $32.7 $8.53 Million - $10.2 Million	-311,000 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$21.37 - $34.38 $8.55 Million - $13.8 Million	-400,000 Reduced 56.26%	311,000 $9.87 Million
Q3 2020 Nov 16, 2020	BUY	$14.88 - $20.13 $297,600 - $402,600	20,000 Added 2.89%	711,000 $11 Million
Q2 2020 Aug 14, 2020	BUY	$13.31 - $20.51 $3.87 Million - $5.97 Million	291,000 Added 72.75%	691,000 $12.6 Million
Q1 2020 May 15, 2020	BUY	$12.98 - $30.25 $5.19 Million - $12.1 Million	400,000 New	400,000 $6.2 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.74B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Silver Rock Financial LP, based on Form 13F filings with the SEC.

Stay updated on Silver Rock Financial LP with notifications on news.